Fernando Rodrigues Sells 2,324 Shares of Teladoc Health (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Fernando Rodrigues sold 2,324 shares of Teladoc Health stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total value of $17,406.76. Following the transaction, the insider directly owned 4,209 shares of the company’s stock, valued at approximately $31,525.41. This represents a 35.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Teladoc Health Stock Up 3.2%

Teladoc Health stock opened at $7.77 on Friday. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The firm has a market capitalization of $1.38 billion, a price-to-earnings ratio of -6.07 and a beta of 2.04. The stock’s fifty day moving average is $8.02 and its two-hundred day moving average is $7.76. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.60 and a current ratio of 2.70.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.05. The business had revenue of $626.44 million during the quarter, compared to the consensus estimate of $625.66 million. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The business’s revenue was down 2.2% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.19) EPS. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on TDOC. Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday. Citigroup increased their target price on Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a report on Tuesday, October 21st. BMO Capital Markets initiated coverage on Teladoc Health in a report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 price target for the company. Bank of America decreased their price objective on Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 25th. Finally, Evercore ISI dropped their price objective on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research report on Thursday, October 30th. Five equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Teladoc Health presently has a consensus rating of “Hold” and a consensus price target of $9.68.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently bought and sold shares of the stock. National Bank of Canada FI raised its stake in Teladoc Health by 79.4% during the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,581 shares during the period. IFP Advisors Inc increased its holdings in shares of Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after buying an additional 3,210 shares during the last quarter. SVB Wealth LLC purchased a new position in shares of Teladoc Health in the 1st quarter worth $37,000. Aster Capital Management DIFC Ltd grew its position in Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 2,425 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Teladoc Health during the first quarter valued at about $50,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.